Q2 Seeds is advancing on a license issued by the Uruguayan government to produce premium medical cannabis seeds with Medropharm genetics. We will start operating in late 2021 in Zonamerica I/O Jacksonville, Montevideo.

Our distinctive product is achieved by an award-winning team of experts and the use of the latest technologies in the industry, and backed with years of research of our strategic partner Medropharm GmbH.

Our goal is to provide top Swiss quality medical cannabis genetics produced in Uruguay and designed to meet the demand of the growing cannabis industry in Latin America and the rest of the world.


Q2 Farma is engaged in a strategic partnership with Swiss company Medropharm GmbH, which specializes in the extraction, production and marketing of pharmaceutical grade cannabinoids and cannabinoid-containing products that make an active contribution to the preservation of health and quality of life.

Medropharm is a leader in researching the medicinal plant Cannabis Sativa and its useful components, and turning them into suitable inputs for the food, cosmetics and pharmaceutical industries.

Our partnership with Medropharm GmbH includes the production and development of industrials and genetics in addition to the exclusive distribution of these top Quality Swiss cannabinoids-based products across the region.


Q2 Clinic is the first international chain of medical cannabis clinics. We provide safe and premium cannabis-based therapies for patients with chronic or debilitating conditions.

We provide our patients premium attention by our international team of highly trained and experienced doctors, led by our Chief Medical Director (CMD), Dr. Peter Grinspoon, MD, primary care physician and cannabis specialist at Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School.

Our mission is to improve patients’ quality of life by providing a high-end family medicine option, with innovative treatments for specific conditions in which medical cannabis therapies have shown effectiveness.

Each patient is unique, and our goal is to give each one of them the best personalized experience by taking all the time we need with them during our concierge-style appointments.

All of our doctors attended the Induction and Leveling Program for Professionals especially designed for Q2 Clinic and directed by Raquel Peyraube, MD, world-class Uruguayan doctor specialized in Endocannabinology.

Q2 Clinic was founded with the objective of constructing a global network of high-end health practices based on the use of medicinal cannabis, a natural product that had been used by ancient cultures for its healing properties and now, through biotechnology advances, is becoming the future of medicine.


Q2 services is a consulting company specialized in medical and industrial cannabis. With a deep understanding of the market and a team of international level professionals, we assist our clients for a successful development in this field. We provide expertise in seeds, genetics, biotechnology, security and registration combined with a business perspective and the optimization of resources.